{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:26:24Z","timestamp":1794669984425,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Umea University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Rheumatoid arthritis (RA) associated interstitial lung disease (ILD) is the most common pulmonary manifestations of RA, with a progressive course and a poor survival. An early detection and better treatment is essential to improve outcome. We evaluated 16 analytes that could be relevant for the development of RA ILD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>In an inception cohort of 1118 early RA patients, pulmonary fibrosis (PF) were identified in 60 patients after a mean follow-up of 5.3 years using high resolution computer tomography (HRCT). As controls, 124 early RA patients without PF and 94 matched population controls without known rheumatic disease were studied. Analysis of antibodies against histones 3 and 4 derived citrullinated peptides (CitH3\/H4), and cytokines\/chemokines levels were performed in plasma samples collected at RA diagnosis using in-house ELISA and Luminex analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>Anti-CitH3(114\u2013135) antibodies were the only antibody with increased frequency and levels in patients with PF versus without PF. The highest OR for PF development were found when combining positivity for anti-CitH3(114\u2013135) and -CitH4(31\u201350) antibodies, OR 2.26. Levels of IL1\u03b1, IL1\u00df, TNF\u03b1, VEGFA and MIP\u03b1 remained significantly elevated in patients with PF compared without PF, after adjustments and Bonferroni corrections. Several of the cytokines\/chemokines correlated significantly with the histone antibodies in patients without PF. Partial least squares discriminant analysis including antibodies against citrullinated histon peptides and cytokines\/chemokines identified significantly in PF in non-smokers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Antibodies against CitH3 peptides and several of the analysed cytokines\/chemokines in samples collected at diagnosis were associated with subsequent delevopment of PF in patients with RA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13075-025-03603-x","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T09:55:10Z","timestamp":1753869310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cytokines, chemokines and antibodies against histone-3\/4 citrullinated peptides in rheumatoid arthritis patients with pulmonary fibrosis"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7071-4699","authenticated-orcid":false,"given":"Linda","family":"Johansson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7226-0907","authenticated-orcid":false,"given":"Federico","family":"Pratesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7790-9886","authenticated-orcid":false,"given":"Fosca","family":"Errante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0737-2213","authenticated-orcid":false,"given":"Lorenzo","family":"Pacini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6433-4964","authenticated-orcid":false,"given":"Paola","family":"Migliorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8259-3863","authenticated-orcid":false,"given":"Solbritt","family":"Rantap\u00e4\u00e4-Dahlqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"3603_CR1","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1002\/acr.24856","volume":"74","author":"BF Samhouri","year":"2022","unstructured":"Samhouri BF, Vassallo R, Achenbach SJ, et al. The incidence, risk factors, and mortality of clinical and subclinical rheumatoid arthritis-associated interstitial lung disease: a population-based cohort. Arthritis Care Res. 2022;74:2042\u20139. https:\/\/doi.org\/10.1002\/acr.24856.","journal-title":"Arthritis Care Res"},{"key":"3603_CR2","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/art.34344","volume":"64","author":"MK Demoruelle","year":"2012","unstructured":"Demoruelle MK, Weisman MH, Simonian PL, et al. Airways abnormalities and rheumatoid arthritis\u2013related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum. 2012;64:1756\u201361. https:\/\/doi.org\/10.1002\/art.34344.","journal-title":"Arthritis Rheum"},{"key":"3603_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/art.38201","volume":"66","author":"G Reynisdottir","year":"2014","unstructured":"Reynisdottir G, Karimi R, Joshua V, et al. Structural changes and antibody enrichment in the lungs are early features of anti\u2013citrullinated protein antibody\u2013positive rheumatoid arthritis. Arthritis Rheumatol. 2014;66:31\u20139. https:\/\/doi.org\/10.1002\/art.38201.","journal-title":"Arthritis Rheumatol"},{"key":"3603_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/art.21575","volume":"54","author":"L Klareskog","year":"2006","unstructured":"Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking May trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006;54:38\u201346. https:\/\/doi.org\/10.1002\/art.21575.","journal-title":"Arthritis Rheum"},{"key":"3603_CR5","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jbspin.2012.01.008","volume":"79","author":"Z Baka","year":"2012","unstructured":"Baka Z, Gy\u00f6rgy B, G\u00e9her P, et al. Citrullination under physiological and pathological conditions. Joint Bone Spine. 2012;79:431\u20136. https:\/\/doi.org\/10.1016\/j.jbspin.2012.01.008.","journal-title":"Joint Bone Spine"},{"key":"3603_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/rheumatology\/kel202","volume":"46","author":"T Bongartz","year":"2007","unstructured":"Bongartz T, Cantaert T, Atkins SR, et al. Citrullination in extra-articular manifestations of rheumatoid arthritis. Rheumatology. 2007;46:70\u20135. https:\/\/doi.org\/10.1093\/rheumatology\/kel202.","journal-title":"Rheumatology"},{"key":"3603_CR7","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1136\/annrheumdis-2012-203160","volume":"73","author":"JT Giles","year":"2014","unstructured":"Giles JT, Danoff SK, Sokolove J, et al. Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease. Ann Rheum Dis. 2014;73:1487\u201394. https:\/\/doi.org\/10.1136\/annrheumdis-2012-203160.","journal-title":"Ann Rheum Dis"},{"key":"3603_CR8","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1136\/annrheumdis-2012-202765","volume":"73","author":"F Pratesi","year":"2014","unstructured":"Pratesi F, Dioni I, Tommasi C, et al. Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps. Ann Rheum Dis. 2014;73:1414\u201322. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202765.","journal-title":"Ann Rheum Dis"},{"key":"3603_CR9","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/art.33432","volume":"64","author":"N Dwivedi","year":"2012","unstructured":"Dwivedi N, Upadhyay J, Neeli I, et al. Felty\u2019s syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps. Arthritis Rheum. 2012;64:982\u201392. https:\/\/doi.org\/10.1002\/art.33432.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3603_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12950-023-00329-y","volume":"20","author":"S Yan","year":"2023","unstructured":"Yan S, Li M, Liu B, Ma Z, Yang Q. Neutrophil extracellular traps and pulmonary fibrosis: an update. J Inflamm (Lond). 2023;20(1):2. https:\/\/doi.org\/10.1186\/s12950-023-00329-y.","journal-title":"J Inflamm (Lond)"},{"key":"3603_CR11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13075-016-1031-0","volume":"18","author":"L Johansson","year":"2016","unstructured":"Johansson L, Pratesi F, Brink M, et al. Antibodies directed against endogenous and exogenous citrullinated antigens pre-date the onset of rheumatoid arthritis. Arthritis Res Ther. 2016;18:127. https:\/\/doi.org\/10.1186\/s13075-016-1031-0.","journal-title":"Arthritis Res Ther"},{"key":"3603_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1164\/rccm.201807-1255ST","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch, et al. D.M. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rhuem. 1988;31:315\u201324. https:\/\/doi.org\/10.1164\/rccm.201807-1255ST.","journal-title":"Arthr Rhuem"},{"issue":"3","key":"3603_CR13","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/rheumatology\/keab441)","volume":"61","author":"E J\u00f6nsson","year":"2022","unstructured":"J\u00f6nsson E, Ljung L, Norrman E, et al. Pulmonary fibrosis in relation to genetic loci in an inception cohort of patients with early rheumatoid arthritis from Northern Sweden. Rheumatology (Oxford). 2022;61(3):943\u201352. https:\/\/doi.org\/10.1093\/rheumatology\/keab441).","journal-title":"Rheumatology (Oxford)"},{"key":"3603_CR14","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198:e44\u201368. https:\/\/doi.org\/10.1164\/rccm.201807-1255ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"3603_CR15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E Von Elm","year":"2008","unstructured":"Von Elm E, Altman DG, Egger M, et al. STROBE initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008.","journal-title":"J Clin Epidemiol"},{"key":"3603_CR16","doi-asserted-by":"publisher","first-page":"R122","DOI":"10.1186\/ar4579","volume":"16","author":"C Chowdhury","year":"2014","unstructured":"Chowdhury C, Giaglis S, Walker UA, et al. Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility. Arthritis Res Ther. 2014;16:R122. https:\/\/doi.org\/10.1186\/ar4579.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"3603_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/cells8020199","volume":"8","author":"M Jezek","year":"2019","unstructured":"Jezek M, Green EM. Histone modifications and the maintenance of telomere integrity. Cells. 2019;8(2):199. https:\/\/doi.org\/10.3390\/cells8020199.","journal-title":"Cells"},{"key":"3603_CR18","doi-asserted-by":"publisher","first-page":"106943","DOI":"10.1016\/j.rmed.2022.106943","volume":"201","author":"JG Natalini","year":"2022","unstructured":"Natalini JG, England BR, Baker JF, et al. Associations between shortened telomeres and rheumatoid arthritis-associated interstitial lung disease among U.S. Veterans. Respir Med. 2022;201:106943. https:\/\/doi.org\/10.1016\/j.rmed.2022.106943.","journal-title":"Respir Med"},{"issue":"2","key":"3603_CR19","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/s2665-9913(22)00380-0","volume":"5","author":"VL Kronzer","year":"2023","unstructured":"Kronzer VL, Hayashi K, Yoshida K, et al. Autoantibodies against citrullinated and native proteins and prediction of rheumatoid arthritis-associated interstitial lung disease: A nested case-control study. Lancet Rheumatol. 2023;5(2):e77\u201387. https:\/\/doi.org\/10.1016\/s2665-9913(22)00380-0.","journal-title":"Lancet Rheumatol"},{"issue":"4","key":"3603_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1513\/pats.200601-010TK","volume":"3","author":"C Agostini","year":"2006","unstructured":"Agostini C, Gurrieri C. Chemokine\/cytokine cocktail in idiopathic pulmonary fibrosis. Proc Am Thorac Soc. 2006;3(4):357\u201363. https:\/\/doi.org\/10.1513\/pats.200601-010TK.","journal-title":"Proc Am Thorac Soc"},{"key":"3603_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.cyto.2017.08.019","volume":"102","author":"SA Papiris","year":"2018","unstructured":"Papiris SA, Tomos IP. High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations. Cytokine. 2018;102:168\u201372. https:\/\/doi.org\/10.1016\/j.cyto.2017.08.019.","journal-title":"Cytokine"},{"issue":"12","key":"3603_CR22","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1172\/JCI32285","volume":"117","author":"P Gasse","year":"2007","unstructured":"Gasse P, Mary C, Guenon I, et al. IL-1R1\/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J Clin Invest. 2007;117(12):3786\u201399. https:\/\/doi.org\/10.1172\/JCI32285.","journal-title":"J Clin Invest"},{"issue":"1","key":"3603_CR23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1165\/rcmb.2012-0524OC","volume":"49","author":"V Aumiller","year":"2013","unstructured":"Aumiller V, Balsara N, Wilhelm J, et al. WNT\/beta-catenin signaling induces IL-1 beta expression by alveolar epithelial cells in pulmonary fibrosis. Am J Resp Cell Mol. 2013;49(1):96\u2013104. https:\/\/doi.org\/10.1165\/rcmb.2012-0524OC.","journal-title":"Am J Resp Cell Mol"},{"key":"3603_CR24","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/1465-9921-10-100","volume":"10","author":"AM Doerner","year":"2009","unstructured":"Doerner AM, Zuraw BL. TGF-beta1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1beta but not abrogated by corticosteroids. Resp Res. 2009;10:100. https:\/\/doi.org\/10.1186\/1465-9921-10-100.","journal-title":"Resp Res"},{"issue":"3","key":"3603_CR25","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/mi.2013.87","volume":"7","author":"MI Suwara","year":"2014","unstructured":"Suwara MI, Green NJ, Borthwick, et al. IL-1 alpha released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts. Mucosal Immunol. 2014;7(3):684\u201393. https:\/\/doi.org\/10.1038\/mi.2013.87.","journal-title":"Mucosal Immunol"},{"key":"3603_CR26","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1084\/jem.170.3.655","volume":"170","author":"PF Piguet","year":"1989","unstructured":"Piguet PF, Collart MA, Grau GE, Kapanci Y, et al. Tumor necrosis factor\/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med. 1989;170:655\u201363. https:\/\/doi.org\/10.1084\/jem.170.3.655.","journal-title":"J Exp Med"},{"key":"3603_CR27","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1183\/09031936.02.00238102","volume":"19","author":"J Libura","year":"2002","unstructured":"Libura J, Bettens F, Radkowski A. Risk of chemotherapy-induced pulmonary fibrosis is associated with polymorphic tumour necrosis factor-a2 gene. Eur Respir J. 2002;19:912\u20138. https:\/\/doi.org\/10.1183\/09031936.02.00238102.","journal-title":"Eur Respir J"},{"issue":"4","key":"3603_CR28","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/pds.3409","volume":"22","author":"LJ Herrinton","year":"2013","unstructured":"Herrinton LJ, Harrold LR, Liu L, et al. Association between anti-TNF-\u03b1 therapy and interstitial lung disease. Pharmacoepidemiol Drug Saf. 2013;22(4):394\u2013402. https:\/\/doi.org\/10.1002\/pds.3409.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"3603_CR29","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3390\/ijms19051269","volume":"19","author":"SL Barratt","year":"2018","unstructured":"Barratt SL, Flower VA, Pauling JD, Millar AB. VEGF (Vascular endothelial growth Factor) and fibrotic lung disease. Int J Mol Sci. 2018;19(5):1269. https:\/\/doi.org\/10.3390\/ijms19051269.","journal-title":"Int J Mol Sci"},{"key":"3603_CR30","doi-asserted-by":"publisher","first-page":"4733","DOI":"10.4049\/jimmunol.153.10.4733","volume":"153","author":"K Zhang","year":"1994","unstructured":"Zhang K, Gharaee-Kermani M, Jones ML. Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis. J Immunol. 1994;153:4733\u201341. https:\/\/doi.org\/10.4049\/jimmunol.153.10.4733.","journal-title":"J Immunol"},{"issue":"3","key":"3603_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1165\/ajrcmb.17.3.2279","volume":"17","author":"C B\u00fcttner","year":"1997","unstructured":"B\u00fcttner C, Skupin A, Reimann T. Local production of interleukin-4 during radiation-induced pneumonitis and pulmonary fibrosis in rats: macrophages as a prominent source of interleukin-4. Am J Respir Cell Mol Biol. 1997;17(3):315\u201325. https:\/\/doi.org\/10.1165\/ajrcmb.17.3.2279.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"3603_CR32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1046\/j.1440-1843.1999.00209","volume":"4","author":"M Ando","year":"1999","unstructured":"Ando M, Miyazaki E, Fukami T, Kumamoto T, Tsuda T. Interleukin-4-producing cells in idiopathic pulmonary fibrosis: an immunohistochemical study. Respirology. 1999;4(4):383\u201391. https:\/\/doi.org\/10.1046\/j.1440-1843.1999.00209.","journal-title":"Respirology"},{"issue":"7","key":"3603_CR33","doi-asserted-by":"publisher","first-page":"6800","DOI":"10.3390\/ijms24076800","volume":"24","author":"N Mena-V\u00e1zquez","year":"2023","unstructured":"Mena-V\u00e1zquez N, Godoy-Navarrete FJ, Lisbona-Monta\u00f1ez JM, et al. Inflammatory biomarkers in the diagnosis and prognosis of rheumatoid Arthritis-Associated interstitial lung disease. Int J Mol Sci. 2023;24(7):6800. https:\/\/doi.org\/10.3390\/ijms24076800.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"3603_CR34","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/art.40904","volume":"71","author":"JA Sparks","year":"2019","unstructured":"Sparks JA, He X, Huang J, Fletcher EA, et al. Rheumatoid arthritis disease activity predicting incident clinically apparent rheumatoid arthritis-Associated interstitial lung disease: A prospective cohort study. Arthritis Rheumatol. 2019;71(9):1472\u201382. https:\/\/doi.org\/10.1002\/art.40904. Epub 2019 Aug 4.","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"3603_CR35","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1093\/rheumatology\/keac280","volume":"61","author":"M Brink","year":"2022","unstructured":"Brink M, Ljung L, Hansson M, R\u00f6nnelid J, Holmdahl R, Skriner K, Serre G, Klareskog L, Rantap\u00e4\u00e4-Dahlqvist S. Anti-citrullinated protein antibody specificities and pulmonary fibrosis in relation to genetic loci in early rheumatoid arthritis. Rheumatology (Oxford). 2022;61(12):4985\u201390. https:\/\/doi.org\/10.1093\/rheumatology\/keac280.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"3603_CR36","doi-asserted-by":"publisher","first-page":"e001363","DOI":"10.1136\/bmjresp-2022-001363","volume":"9","author":"J Salonen","year":"2022","unstructured":"Salonen J, Purokivi M, Hodgson U, Kaarteenaho R. National data on prevalence of idiopathic pulmonary fibrosis and antifibrotic drug use in Finnish specialised care. BMJ Open Respir Res. 2022;9(1):e001363. https:\/\/doi.org\/10.1136\/bmjresp-2022-001363.","journal-title":"BMJ Open Respir Res"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03603-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03603-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03603-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T06:03:43Z","timestamp":1753941823000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03603-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3603"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03603-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6420648\/v1","asserted-by":"object"}]},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adheres to the principles of the Declaration of Helsinki, and ethical approval was obtained from the Regional Ethics Committee at Ume\u00e5 University, Sweden (Approval Numbers: Dnr 2017-432-32\u00a0M, 2019\u201302039, 2022-06100-01). All participating patients provided informed consent before participating in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors have given their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"160"}}